These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32895384)

  • 1. Purification of HCC-specific extracellular vesicles on nanosubstrates for early HCC detection by digital scoring.
    Sun N; Lee YT; Zhang RY; Kao R; Teng PC; Yang Y; Yang P; Wang JJ; Smalley M; Chen PJ; Kim M; Chou SJ; Bao L; Wang J; Zhang X; Qi D; Palomique J; Nissen N; Han SB; Sadeghi S; Finn RS; Saab S; Busuttil RW; Markovic D; Elashoff D; Yu HH; Li H; Heaney AP; Posadas E; You S; Yang JD; Pei R; Agopian VG; Tseng HR; Zhu Y
    Nat Commun; 2020 Sep; 11(1):4489. PubMed ID: 32895384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
    Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma.
    Kim SS; Baek GO; Ahn HR; Sung S; Seo CW; Cho HJ; Nam SW; Cheong JY; Eun JW
    Mol Oncol; 2020 Oct; 14(10):2646-2659. PubMed ID: 32525601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets' RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules.
    Waqar W; Asghar S; Manzoor S
    PLoS One; 2021; 16(9):e0256739. PubMed ID: 34469466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma.
    Wang X; Kwak KJ; Yang Z; Zhang A; Zhang X; Sullivan R; Lin D; Lee RL; Castro C; Ghoshal K; Schmidt C; Lee LJ
    PLoS One; 2018; 13(6):e0198552. PubMed ID: 29879168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle-derived long noncoding RNAs identified as markers.
    Kim SS; Baek GO; Son JA; Ahn HR; Yoon MK; Cho HJ; Yoon JH; Nam SW; Cheong JY; Eun JW
    Mol Oncol; 2021 Oct; 15(10):2715-2731. PubMed ID: 34185961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma.
    Sun N; Zhang C; Lee YT; Tran BV; Wang J; Kim H; Lee J; Zhang RY; Wang JJ; Hu J; Zhang Z; Alsudaney MS; Hou KC; Tang H; Zhang TX; Liang IY; Zhou Z; Chen M; Yeh AH; Li W; Zhou XJ; Chang HR; Han SB; Sadeghi S; Finn RS; Saab S; Busuttil RW; Noureddin M; Ayoub WS; Kuo A; Sundaram V; Al-Ghaieb B; Palomique J; Kosari K; Kim IK; Todo T; Nissen NN; Tomasi ML; You S; Posadas EM; Wu JX; Wadehra M; Sim MS; Li Y; Wang HL; French SW; Lu SC; Wu L; Pei R; Liang L; Yang JD; Agopian VG; Tseng HR; Zhu Y
    Hepatology; 2023 Mar; 77(3):774-788. PubMed ID: 35908246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum pentraxin 3 as a biomarker of hepatocellular carcinoma in chronic hepatitis B virus infection.
    Deng H; Fan X; Wang X; Zeng L; Zhang K; Zhang X; Li N; Han Q; Lv Y; Liu Z
    Sci Rep; 2020 Nov; 10(1):20276. PubMed ID: 33219288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Glypican3 be diagnostic for early hepatocellular carcinoma among Egyptian patients?
    Abdelgawad IA; Mossallam GI; Radwan NH; Elzawahry HM; Elhifnawy NM
    Asian Pac J Cancer Prev; 2013; 14(12):7345-9. PubMed ID: 24460300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter analysis of soluble Axl reveals diagnostic value for very early stage hepatocellular carcinoma.
    Reichl P; Fang M; Starlinger P; Staufer K; Nenutil R; Muller P; Greplova K; Valik D; Dooley S; Brostjan C; Gruenberger T; Shen J; Man K; Trauner M; Yu J; Gao CF; Mikulits W
    Int J Cancer; 2015 Jul; 137(2):385-394. PubMed ID: 25529751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
    El-Mazny A; Sayed M; Sharaf S
    Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis B.
    Omar H; Lim CR; Chao S; Lee MM; Bong CW; Ooi EJ; Yu CG; Tan SS; Abu Hassan MR; Menon J; Muthukaruppan R; Singh M; Nik Abdullah NA; Ooi BP; Ding RP; Low EJ; Tan F; Novak D; Harris DF; Yang H; Merican I; Liew CC
    J Clin Gastroenterol; 2015 Feb; 49(2):150-7. PubMed ID: 25569223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
    Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
    Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis.
    Patel J; Yopp A; Waljee AK; Singal AG
    J Clin Gastroenterol; 2016 Feb; 50(2):175-9. PubMed ID: 26125462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel biomarker TERTmRNA is applicable for early detection of hepatoma.
    Miura N; Osaki Y; Nagashima M; Kohno M; Yorozu K; Shomori K; Kanbe T; Oyama K; Kishimoto Y; Maruyama S; Noma E; Horie Y; Kudo M; Sakaguchi S; Hirooka Y; Ito H; Kawasaki H; Hasegawa J; Shiota G
    BMC Gastroenterol; 2010 May; 10():46. PubMed ID: 20482774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Biomarker Panel for the Early Detection and Risk Assessment of Hepatocellular Carcinoma in Patients with Cirrhosis.
    Khan IM; Gjuka D; Jiao J; Song X; Wang Y; Wang J; Wei P; El-Serag HB; Marrero JA; Beretta L
    Cancer Prev Res (Phila); 2021 Jun; 14(6):667-674. PubMed ID: 33685927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HCC and Tumor Biomarkers: Does One Size Fits All?
    Ozgor D; Otan E
    J Gastrointest Cancer; 2020 Dec; 51(4):1122-1126. PubMed ID: 32827068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
    Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
    Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Extracellular Vesicle-Derived microRNAs as Novel Diagnostic and Prognostic Biomarkers for Non-Viral-Related Hepatocellular Carcinoma.
    Boonkaew B; Satthawiwat N; Pinjaroen N; Chuaypen N; Tangkijvanich P
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five miRNAs identified in fucosylated extracellular vesicles as non-invasive diagnostic signatures for hepatocellular carcinoma.
    Li B; Hao K; Li M; Wang A; Tang H; Xu L; Ma C; Du W; Sun L; Hou X; Jia T; Liu A; Gao Q; Zhao Z; Jin R; Yang R
    Cell Rep Med; 2024 Sep; 5(9):101716. PubMed ID: 39241773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.